Winson ID

Winson ID is a biotechnology company specializing in the development and commercialization of advanced diagnostic solutions, particularly for infectious diseases. The company gained significant prominence for its rapid diagnostic testing platforms, which were widely utilized during the COVID-19 pandemic for efficient screening and identification. Winson ID focuses on integrating molecular biology with innovative engineering to provide high-sensitivity, point-of-care testing systems. Their products are designed to streamline clinical workflows and provide actionable results in a fraction of the time required by traditional laboratory methods. The company continues to expand its diagnostic portfolio to address a broader range of pathogens and clinical needs.